Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 4Terminated 4Completed 3Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4

Conditions

Breast Neoplasms 1476Neoplasms 999Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 647Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 292Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

surufatinib 1pemigatinib 1Vinorelbine 1Pemetrexed 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × Advanced Non-Small Cell Lung Cancer × Clear all
NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 2 Unknown
60 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT06174857 2023-12-18

Efficacy of Osimertinib in Patients With Lung Cancer

Hunan Province Tumor Hospital

Unknown
100 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT05287386 2022-03-18

A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy

The First Affiliated Hospital of Xiamen University

Phase 2 Unknown
20 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00786331 2009-08-03

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Unknown
230 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡